Global Wilson's Disease Market Growth (Status and Outlook) 2023-2029

Global Wilson's Disease Market Growth (Status and Outlook) 2023-2029

Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.
LPI (LP Information)' newest research report, the “Wilson's Disease Industry Forecast” looks at past sales and reviews total world Wilson's Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Wilson's Disease sales for 2023 through 2029. With Wilson's Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Wilson's Disease industry.
This Insight Report provides a comprehensive analysis of the global Wilson's Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Wilson's Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Wilson's Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Wilson's Disease and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Wilson's Disease.
The global Wilson's Disease market size is projected to grow from US$ 199.7 million in 2022 to US$ 269.1 million in 2029; it is expected to grow at a CAGR of 4.4% from 2023 to 2029.
The classification of Wilson’s disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson’s disease. Penicillamine is the most successful drug used for the treatment of Wilson’s disease. Wilson’s disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson’s disease is Drugs Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. Market competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.
This report presents a comprehensive overview, market shares, and growth opportunities of Wilson's Disease market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Trientine
Penicillamine
Others
Segmentation by application
Hospital
Drugs Stores
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bausch Health
Teva
Endo International
Univar Solutions
MSN Laboratories
ANI Pharmaceuticals
APOTEX
Tsumura
Sinepharm
Taj Pharmaceutical
Kadmon Holdings

Please note: The report will take approximately 2 business days to prepare and deliver.